Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for Methamphetamine Dependence in MSM
NCT00497081Phase 2Completed
- Sponsor
- San Francisco Department of Public Health
- Start
- May 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in methamphetamine use disorder (MUD) comparing Mirtazapine with Placebo (2 arms). Primary endpoints: Change in Number of Positive Methamphetamine Urine Tests at 12 weeks, Proportion of Days With Recorded Pill Bottle Opening at 12 weeks and 1 more. Started May 2007; status: completed.
02
Drugs
mirtazapine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT00497081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00497081.